Skip to content

Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults

Health Beliefs, Behaviors, and Healthcare Experiences Among a National Sample of United States Young and Mid-Age Adults

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04766164
Enrollment
4000
Registered
2021-02-23
Start date
2021-02-17
Completion date
2022-07-06
Last updated
2022-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV Vaccine Knowledge

Keywords

HPV, HPV Vaccine

Brief summary

The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals.

Detailed description

The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals. In addition, the study will illuminate gaps in knowledge and awareness as well as the education intervention preferences (e.g., intervention platform, source of information, timing of intervention) of individuals ages 18-45. Among those ages 27-45, shared clinical decision-making is recommended. Compared to individuals ages 18-26, individuals ages 27-45 may need to be supported uniquely so that they are prepared to engage in shared clinical decision-making about HPV vaccination with their healthcare provider. Thus, among unvaccinated individuals ages 27-45, for whom shared clinical decision-making is recommended, preparedness for engagement in shared clinical decision-making will be assessed and explored. The study also will allow investigators to identify how best to target information to young adults and mid-adults both for themselves, and among those with children, for their children.

Interventions

BEHAVIORALSurvey

Data will be obtained via self-report from participants via a one-time Qualtrics survey.

Sponsors

H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years

Inclusion criteria

* Age 18-45 * Living in the United States * a KnowledgePanel panelist directly or via verified partners * Have internet access * Able to read, write and understand English * Individuals can participant regardless of their HPV vaccination status

Exclusion criteria

* Individuals who do not meet inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
HPV Vaccine KnowledgeDay 1Data from survey will describe HPV and HPV vaccine knowledge, health beliefs, attitudes, affect, health literacy, health care experiences, vaccine discussions and information sources, preparedness for shared decision-making and HPV vaccine uptake and intentions and examine relationships between these variables among a national sample of U.S. adults (N=4,000) ages 18-45 years.
HPV-Related Educational Intervention PreferencesDay 1Data from survey will describe intervention preferences and associations between intervention preferences and sociodemographic variables (e.g., age, gender, race, ethnicity, socioeconomic status, employment status, parental status, and insurance status).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026